Hydrocortison Teva (Hydrocortisone)

Hydrocortison Teva is indicated for the oral replacement of cortisol in patients with specific adrenal disorders.

• Adrenal insufficiency, including primary and secondary forms.
• Addison’s disease, a chronic condition characterized by inadequate adrenal hormone production.
• Congenital adrenal hyperplasia, a genetic disorder affecting cortisol synthesis.
• Situations where temporary glucocorticoid supplementation is required, such as during stress or illness.

• Hydrocortison Teva works by acting as an agonist at the intracellular glucocorticoid receptor. After oral absorption, hydrocortisone binds to the receptor, translocates to the nucleus, and modulates gene transcription. This leads to decreased production of pro‑inflammatory cytokines and suppression of immune cell activity, while also providing the physiological glucocorticoid activity needed to maintain metabolic, cardiovascular, and stress‑response functions.

Like other systemic glucocorticoids, hydrocortisone may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common

• Increased appetite or weight gain.
• Fluid retention causing mild edema.
• Elevated blood glucose levels, especially in diabetic patients.
• Mood changes such as irritability or anxiety.
• Gastrointestinal discomfort, including nausea.

Serious

• Severe infections due to immunosuppression.
• Significant hypertension or worsening of existing cardiovascular disease.
• Osteoporosis or increased risk of fractures with long‑term use.
• Adrenal suppression leading to crisis if medication is abruptly stopped.
• Allergic reactions such as rash, urticaria, or anaphylaxis.

Healthcare providers should evaluate several safety considerations before initiating Hydrocortison Teva therapy.

• Assess for active infections, as glucocorticoids can exacerbate them.
• Monitor blood glucose and blood pressure regularly during treatment.
• Use the lowest effective dose for the shortest duration needed to avoid long‑term complications.
• Screen for a history of peptic ulcer disease or gastrointestinal bleeding.
• Caution in patients with osteoporosis, psychiatric disorders, or cardiovascular disease.
• Avoid abrupt discontinuation to prevent adrenal insufficiency; tapering is recommended under medical supervision.

Hydrocortison Teva can interact with other medicines, affecting either drug levels or clinical response.

Avoid

• Strong CYP3A4 inducers such as rifampin, which may reduce hydrocortisone concentrations.
• Live vaccines, because immunosuppression can diminish vaccine efficacy and increase infection risk.

Use with caution

• Anticoagulants (e.g., warfarin) as glucocorticoids may enhance anticoagulant effect.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) which can increase the risk of gastrointestinal ulceration.
• Diabetic medications, since hydrocortisone may raise blood glucose.
• Antihypertensive agents, as fluid retention may counteract blood pressure control.